Blaine Davis

Insider Reports History

Entity
Individual
Location
C/O Artara Therapeutics, Inc., 1 Little West 12 Th Street, New York, NY
Signature
Matthew Bartholomae, Attorney-in-Fact for Blaine Davis
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Blaine Davis:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cartesian Therapeutics, Inc. Chief Financial Officer Common Stock 2.42M $4.99M $2.06 Jan 2, 2024 Direct
Cartesian Therapeutics, Inc. Chief Financial Officer Employee Stock Option (right to buy) 3.11M $2.46M $0.79 Jan 2, 2024 Direct
Protara Therapeutics, Inc. Chief Financial Officer Common Stock 20.7K $39.5K $1.91 Jul 15, 2022 Direct
Protara Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 84.8K Jan 3, 2022 Direct

Insider Reports Filed by Blaine Davis

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RNAC Cartesian Therapeutics, Inc. Jan 2, 2024 2 $0 4 Jan 4, 2024 Chief Financial Officer
SELB Cartesian Therapeutics, Inc. Nov 13, 2023 1 -$988K 4 Nov 15, 2023 Chief Financial Officer
SELB SELECTA BIOSCIENCES INC Nov 28, 2022 1 $0 4 Nov 30, 2022 Chief Financial Officer
SELB SELECTA BIOSCIENCES INC Nov 28, 2022 0 $0 3 Nov 30, 2022 Chief Financial Officer
TARA Protara Therapeutics, Inc. Jul 15, 2022 1 -$15.9K 4 Jul 19, 2022 Chief Financial Officer
TARA Protara Therapeutics, Inc. Jan 3, 2022 2 $0 4 Jan 5, 2022 Chief Financial Officer